Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole

Exclusion Criteria

• •Patients with the following retinal disorders: age-related macular degeneration, epi-macular membrane neovascularization, non-macular retinal tears, lesions of the retinal pigment epithelium and choroid, inherited or degenerative retinal diseases, optic neuropathies, retinal vascular diseases; patients with large macular holes accompanied by retinal detachment;
• •Patients with high myopia (axial length ≥ 26.0mm and myopia exceeding 6D);
• •Patients with a history of ocular trauma or retinal laser treatment;
• •Patients with glaucoma, ocular infections, inflammations, tumors, corneal diseases, or amblyopia;
• •Patients with contraindications to vitrectomy;
• •Patients with severe or unstable systemic diseases;
• •Patients with a fasting blood glucose level ≥ 9mmol/L before surgery;
• •Patients who participated in other clinical trials involving drugs or medical devices within 30 days prior to screening;
• •Patients with a history of intraocular surgery within 3 months prior to screening;
• •Patients with reduced visual function or vision in the contralateral eye as determined by the investigator;
• •Patients who are not considered suitable for enrollment by the investigator for other reasons.